Skip to content

Orofacial Pain in Multiple Sclerosis

Orofacial Pain in Multiple Sclerosis

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06021561
Enrollment
0
Registered
2023-09-01
Start date
2023-09-04
Completion date
2023-12-31
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

facial pain, craniofacial pain, multiple sclerosis

Brief summary

Although the orofacial pain is not typical symptom of multiple sclerosis, more than 50% of the patients experience some kind of pain. Acute pain usually in form of trigeminal neuralgia, that occurred in 2-3% of patients with multiple sclerosis. Chronic pain occurred in 40-50% of patients and most common forms are headache. Aim of this study is to investigate prevalence and evaluate the form of orofacial pain in patients with multiple sclerosis treated in General hospital Varaždin in period from 01.01. 2017. to 31.12.2022. Results of this investigation will determine better understanding orofacial pain , treatment and impact on everyday life.

Detailed description

Multiple sclerosis is a chronic autoimmune disease with an unknown mechanism of origin. Although pain is not a typical symptom of multiple sclerosis, it occurs in more than 50% of patients and has significant impact on the quality of life of patients. Pain syndromes that patients with multiple sclerosis initially have characteristics of somatic and nociceptive pain, and later neuropathic, including trigeminal neuralgia, headaches, Lhermitte's syndrome. Pain is also often associated with anxiety and depression, which occurs in almost one third of patients. Pain therapy in these patients is a challenge for many doctors involved in the treatment. Many patients do not have adequate pain therapy due to the disproportion between the fear of interaction with other drugs and side effects, and on the other hand the treatment of basic diseases with the aim of controlling the immune response.

Interventions

DIAGNOSTIC_TESTDiagnosis of pain

Pain will be investigated - type, origin, level

Sponsors

Varazdin General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* multiple scerosis * age 18-85 years

Exclusion criteria

* records with missing data

Design outcomes

Primary

MeasureTime frameDescription
The frequency of orofacial pain in patients with multiple sclerosis3 monthsTo investigate that, hospital records will be reviewed. Additionally, all of the patients will be approached with the questionnaire investigating the frequency of orofacial pain (expressed in number and proportion of all patients)
The location of orofacial pain in patients with multiple sclerosis3 monthsTo investigate that, hospital records will be reviewed. Additionally, all of the patients will be approached with the questionnaire investigating the loacation of orofacial pain
The duration of orofacial pain in patients with multiple sclerosis3 monthsTo investigate that, hospital records will be reviewed. Additionally, all of the patients will be approached with the questionnaire investigating the duration of orofacial pain (in months)

Secondary

MeasureTime frameDescription
Other chronic diseases and orofacial pain3 monthsTo investigate the influence of other chronic diseases on orofacial pain in patients with multiple sclerosis
MS therapy's influence to pain3 monthsTo investigate connection between orofacial pain and multiple sclerosis therapy
Pain and daily functioning3 monthsTo investigate the impact of pain on the daily functioning of patients with multiple sclerosis
MS orofacial pain and the duration of the disease3 monthsTo investigate the connection between orofacial pain and the duration of the disease
Pain and patients' characteristics3 monthsTo investigate the pain characteristics in relation to age, sex, form of the disease

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026